James Arthur Bristol, Director at Deciphera Pharmaceuticals, Inc. (DCPH), sold 7,000 shares at $50.21 ($352K) on 2021-01-15, disclosed to the SEC on 2021-01-20.
Open-market sale of $352k DCPH by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.21 | 6,400 | $321K | 91.3% |
| 2 | $51.11 | 600 | $31K | 8.7% |
| Total | $50.29 avg | 7,000 | $352K | 100% |
| Filing → |
| DCPH | SELL | 2021-04-14 | $1.3M | — | Filing → |
| DCPH | SELL | 2020-10-13 | $2.5M | — | Filing → |
| DCPH | SELL | 2020-07-13 | $2.6M | — | Filing → |